Boehringer Ingelheim, founded in 1885 by Albert Boehringer in Ingelheim, Germany, began with just 28 people employed to manufacture tartaric acid salts. We are now one of the world’s top 20 leading pharmaceutical companies and a global enterprise that employs more than 44,000 people in 50 countries. Our focus is primarily in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. For over 125 years, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value.
BI is committed to providing more health to more people in more communities around the world. Through our dedicated and caring employees and our commitment to leading-edge research and innovation, we are a leading provider of human pharmaceuticals, prescription medicines, consumer health care, biopharmaceuticals, and animal health medicines.
The US headquarters, located in Ridgefield Connecticut is the largest subsidiary of the Boehringer Ingelheim group. There are over 10,000 employees across the US in our Boehringer Ingelheim subsidiaries located in Atlanta, Connecticut, California, Ohio, Missouri and Iowa.
To learn more about the financial highlights, the corporate vision, the organization, the Board of Managing Directors, job opportunities and the company's history as well as our engagement for scientific, cultural and environmental purposes, please visit http://www.boehringer-ingelheim.com/
To search for global job opportunities, please visit our career portal: